Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models

A panel of clinically used tyrosine kinase inhibitors was compared and nilotinib was found to most potently sensitize specific anticancer agents by blocking the functions of ABCB1/P-glycoprotein, ABCG2/BCRP and ABCC10/MRP7 transporters involved in multi-drug resistance. Nilotinib appreciably enhance...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Tiwari, Amit K., Sodani, Kamlesh, Dai, Chun-ling, Abuznait, Alaa H., Singh, Satyakam, Xiao, Zhi-Jie, Patel, Atish, Talele, Tanaji T., Fu, Liwu, Kaddoumi, Amal, Gallo, James M., Chen, Zhe-Sheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513659/
https://ncbi.nlm.nih.gov/pubmed/23063650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2012.10.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi